ASRM: Ovulation Induction, Ovulation Drugs

Ovulation Induction and Ovulation Drugs

This web page contains links to ASRM publications and materials on the general subject of Ovulation Detection, Ovulation Induction and Ovulation Drugs. Some materials are archived in Adobe®Acrobat® PDF format. Please click here for downloading information.

ASRM Patient Education Fact Sheet: Ovulation Detection (PDF) (June 2006)

Ovulation Induction

ASRM Practice Guideline: Multiple pregnancy associated with infertility therapy published November 2006; revised June 2006. Practice Committee Guidelines are accessible to ASRM members only
ASRM Practice Guideline: Ovarian hyperstimulation syndrome published November 2006; reviewed June 2006. Practice Committee Guidelines are accessible to ASRM members only

Ovulation Drugs

ASRM Patient Education Fact Sheet: Fertility Drugs and the Risks of Multiple Births (PDF) (May 2008)
ASRM Practice Guideline: Use of clomiphene citrate in women published November 2006; reviewed June 2006. Practice Committee Guidelines are accessible to ASRM members only
Induction of ovulation and ovarian cancer: a critical review of the literature from Fertil Steril 2006;85:819-26. (PDF)
Infertility Drugs and the Risk of Breast Cancer: Findings From the National Institute of Child Health and Human Development Women's Contraceptive and Reproductive Experiences Study from Fertil Steril 79:844-51. (PDF)
ASRM Patient Booklet: Medications for Inducing Ovulation (PDF) (2006)
ASRM Patient Education Fact Sheet: Side Effects of Gonadotropins (PDF) (November 2005)

See also the following topics:

Multiple Gestation

For more information on the manufacturers of Ovulation Drugs, please visit the ASRM Corporate Member Council.

Return to Topic Index

By accessing and using the ASRM Web Site, you agree to be bound by
the ASRM Web Site Terms and Conditions of Use.

View the ASRM Non Discrimination Policy

Listed on Infertility Resources
Developed and hosted by Internet Health Resources